We found that in mice, downregulation of IL-17A expression in A549 cells prevented bone destruction caused by tumor metastasis in vivo, with a significant reduction in the number of osteoclasts on the bone surface in mice injected with IL-17A-deficient A549 cells. Here, IL17A is linked to neoplasm.